|
1
|
Edwards BK, Brown ML, Wingo PA, Howe HL,
Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, et al:
Annual report to the nation on the status of cancer, 1975–2002,
featuring population-based trends in cancer treatment. J Natl
Cancer Inst. 97:1407–1427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Persson S, Edlund MB, Claesson R and
Carlsson J: The formation of hydrogen sulfide and methyl mercaptan
by oral bacteria. Oral Microbiol Immunol. 5:195–201. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie L, Feng H, Li S, Meng G, Liu S, Tang
X, Ma Y, Han Y, Xiao Y, Gu Y, et al: SIRT3 mediates the antioxidant
effect of hydrogen sulfide in endothelial cells. Antioxid Redox
Signal. 24:329–343. 2016. View Article : Google Scholar
|
|
5
|
Xie ZZ, Shi MM, Xie L, Wu ZY, Li G, Hua F
and Bian JS: Sulfhydration of p66Shc at cysteine59 mediates the
antioxidant effect of hydrogen sulfide. Antioxid Redox Signal.
21:2531–2542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heneberg P: Reactive nitrogen species and
hydrogen sulfide as regulators of protein tyrosine phosphatase
activity. Antioxid Redox Signal. 20:2191–2209. 2014. View Article : Google Scholar :
|
|
7
|
Calvert JW, Jha S, Gundewar S, Elrod JW,
Ramachandran A, Pattillo CB, Kevil CG and Lefer DJ: Hydrogen
sulfide mediates cardioprotection through Nrf2 signaling. Circ Res.
105:365–374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salloum FN, Chau VQ, Hoke NN, Abbate A,
Varma A, Ockaili RA, Toldo S and Kukreja RC: Phosphodiesterase-5
inhibitor, tadalafil, protects against myocardial
ischemia/reperfusion through protein-kinase g-dependent generation
of hydrogen sulfide. Circulation. 120(Suppl 11): S31–S36. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondo K, Bhushan S, King AL, Prabhu SD,
Hamid T, Koenig S, Murohara T, Predmore BL, Gojon G Sr, Gojon G Jr,
et al: H2S protects against pressure overload-induced
heart failure via upregulation of endothelial nitric oxide
synthase. Circulation. 127:1116–1127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Badiei A, Rivers-Auty J, Ang AD and Bhatia
M: Inhibition of hydrogen sulfide production by gene silencing
attenuates inflammatory activity of LPS-activated RAW264.7 cells.
Appl Microbiol Biotechnol. 97:7845–7852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miller TW, Wang EA, Gould S, Stein EV,
Kaur S, Lim L, Amarnath S, Fowler DH and Roberts DD: Hydrogen
sulfide is an endogenous potentiator of T cell activation. J Biol
Chem. 287:4211–4221. 2012. View Article : Google Scholar :
|
|
12
|
Mok YY and Moore PK: Hydrogen sulphide is
pro-inflammatory in haemorrhagic shock. Inflamm Res. 57:512–518.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szabo C, Coletta C, Chao C, Módis K,
Szczesny B, Papapetropoulos A and Hellmich MR: Tumor-derived
hydrogen sulfide, produced by cystathionine-β-synthase, stimulates
bioenergetics, cell proliferation, and angiogenesis in colon
cancer. Proc Natl Acad Sci USA. 110:12474–12479. 2013. View Article : Google Scholar
|
|
14
|
Elsheikh W, Blackler RW, Flannigan KL and
Wallace JL: Enhanced chemopreventive effects of a hydrogen
sulfide-releasing anti-inflammatory drug (ATB-346) in experimental
colorectal cancer. Nitric Oxide. 41:131–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gokdogan O, Catli T and Ileri F: Halitosis
in otorhinolaryngology practice. Iran J Otorhinolaryngol.
27:145–153. 2015.PubMed/NCBI
|
|
16
|
Motta JP, Flannigan KL, Agbor TA, Beatty
JK, Blackler RW, Workentine ML, Da Silva GJ, Wang R, Buret AG and
Wallace JL: Hydrogen sulfide protects from colitis and restores
intestinal microbiota biofilm and mucus production. Inflamm Bowel
Dis. 21:1006–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang JH, Dong Z and Chu L: Hydrogen
sulfide induces apoptosis in human periodontium cells. J
Periodontal Res. 45:71–78. 2010. View Article : Google Scholar
|
|
18
|
Ma Z, Bi Q and Wang Y: Hydrogen sulfide
accelerates cell cycle progression in oral squamous cell carcinoma
cell lines. Oral Dis. 21:156–162. 2015. View Article : Google Scholar
|
|
19
|
Balasenthil S, Rao KS and Nagini S:
Apoptosis induction by S-allylcysteine, a garlic constituent,
during 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch
carcinogenesis. Cell Biochem Funct. 20:263–268. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morita M and Wang HL: Association between
oral malodor and adult periodontitis: A review. J Clin Periodontol.
28:813–819. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen YD and Zhu YZ: The pharmacological
effects of S-propargyl-cysteine, a novel endogenous
H2S-producing compound. Handbook Exp Pharmacol.
230:325–336. 2015. View Article : Google Scholar
|
|
22
|
Kim BM, Maeng K, Lee KH and Hong SH:
Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ
ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis
in human lung cancer cells. Cancer Lett. 300:134–144. 2011.
View Article : Google Scholar
|
|
23
|
Larkins TL, Nowell M, Singh S and Sanford
GL: Inhibition of cyclooxygenase-2 decreases breast cancer cell
motility, invasion and matrix metalloproteinase expression. BMC
Cancer. 6:1812006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brueggemeier RW, Díaz-Cruz ES, Li PK,
Sugimoto Y, Lin YC and Shapiro CL: Translational studies on
aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
J Steroid Biochem Mol Biol. 95:129–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Guo J, Huang D and Cheng W:
Correlation of volatile sulfide compounds in the oral cavity with
periodontitis and tongue coating. Zhongguo Shengwu Yixue Gongcheng
Xuebao. 18:149–152. 2012.In Chinese.
|
|
26
|
Moore PK, Bhatia M and Moochhala S:
Hydrogen sulfide: From the smell of the past to the mediator of the
future? Trends Pharmacol Sci. 24:609–611. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Looby E, Abdel-Latif MM, Athié-Morales V,
Duggan S, Long A and Kelleher D: Deoxycholate induces COX-2
expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in
esophageal cancer cells. BMC Cancer. 9:1902009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Greenhough A, Smartt HJ, Moore AE, Roberts
HR, Williams AC, Paraskeva C and Kaidi A: The COX-2/PGE2 pathway:
Key roles in the hallmarks of cancer and adaptation to the tumour
micro-environment. Carcinogenesis. 30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang ZM, Liu J, Liu HB, Ye M, Zhang YF and
Yang DS: Abnormal COX2 protein expression may be correlated with
poor prognosis in oral cancer: A meta-analysis. Biomed Res Int.
2014:3642072014.PubMed/NCBI
|
|
30
|
Chambard JC, Lefloch R, Pouysségur J and
Lenormand P: ERK implication in cell cycle regulation. Biochim
Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar
|
|
31
|
Rasola A, Sciacovelli M, Chiara F, Pantic
B, Brusilow WS and Bernardi P: Activation of mitochondrial ERK
protects cancer cells from death through inhibition of the
permeability transition. Proc Natl Acad Sci USA. 107:726–731. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng CY, Hu CC, Yang HJ, Lee MC and Kao
ES: Inhibitory effects of scutellarein on proliferation of human
lung cancer A549 cells through ERK and NFκB mediated by the EGFR
pathway. Chin J Physiol. 57:182–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ,
Sun RH, Wu Y and Han M: Baicalin inhibits PDGF-BB-stimulated
vascular smooth muscle cell proliferation through suppressing
PDGFRβ-ERK signaling and increase in p27 accumulation and prevents
injury-induced neointimal hyperplasia. Cell Res. 20:1252–1262.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye Y, Ge YM, Xiao MM, Guo LM, Li Q, Hao
JQ, Da J, Hu WL, Zhang XD, Xu J, et al: Suppression of SHIP2
contributes to tumorigenesis and proliferation of gastric cancer
cells via activation of Akt. J Gastroenterol. Jul 23–2015.(Epub
ahead of print). http://dx.doi.org/10.1007/s00535-015-1101-0.
PubMed/NCBI
|
|
35
|
Huang H, Song Y, Wu Y, Guo N, Ma Y and
Qian L: Erbin loss promotes cancer cell proliferation through
feedback activation of Akt-Skp2-p27 signaling. Biochem Biophys Res
Commun. 463:370–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yallapu MM, Khan S, Maher DM, Ebeling MC,
Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, et
al: Anti-cancer activity of curcumin loaded nanoparticles in
prostate cancer. Biomaterials. 35:8635–8648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rick FG, Schally AV, Szalontay L, Block
NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S and Seitz
S: Antagonists of growth hormone-releasing hormone inhibit growth
of androgen-independent prostate cancer through inactivation of ERK
and Akt kinases. Proc Natl Acad Sci USA. 109:1655–1660. 2012.
View Article : Google Scholar : PubMed/NCBI
|
